Urinary Melatonin Levels and Breast Cancer Risk
Open Access
- 20 July 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 97 (14), 1084-1087
- https://doi.org/10.1093/jnci/dji190
Abstract
Exposure to light at night suppresses melatonin production, and night-shift work (a surrogate for such exposure) has been associated with an increased risk of breast cancer. However, the association between circulating melatonin levels and breast cancer risk is unclear. In a prospective case–control study nested within the Nurses' Health Study II cohort, we measured the concentration of the major melatonin metabolite, 6-sulphatoxymelatonin (aMT6s), in the first morning urine of 147 women with invasive breast cancer and 291 matched control subjects. In logistic regression models, the relative risk (reported as the odds ratio [OR]) of invasive breast cancer for women in the highest quartile of urinary aMT6s compared with those in the lowest was 0.59 (95% confidence interval [CI] = 0.36 to 0.97). This association was essentially unchanged after adjustment for breast cancer risk factors or plasma sex hormone levels but was slightly weakened when the analysis included 43 case patients with in situ breast cancer and their 85 matched control subjects (OR = 0.70, 95% CI = 0.47 to 1.06). The exclusion of women who had a history of night-shift work left our findings largely unchanged. These prospective data support the hypothesis that higher melatonin levels, as measured in first morning urine, are associated with a lower risk of breast cancer.Keywords
This publication has 32 references indexed in Scilit:
- Dietary flavonols and flavonol‐rich foods intake and the risk of breast cancerInternational Journal of Cancer, 2004
- Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiologyReviews of Reproduction, 1998
- 6-Sulphatoxymelatonin Production in Breast Cancer PatientsJournal of Pineal Research, 1990
- Plasma Melatonin in Patients with Breast CancerOncology, 1990
- Pineal Gland and Tumor Cell Kinetics: Serum Levels of Melatonin in Relation to Ki-67 Labeling Rate in Breast CancerOncology, 1990
- The clinical significance of melatonin serum determination in oncological patients and its correlations with GH and PRL blood levelsEuropean Journal of Cancer and Clinical Oncology, 1987
- Melatonin in relation to body measures, sex, age, season and the use of drugs in patients with major affective disorders and healthy subjectsPsychoneuroendocrinology, 1983
- Percentage Points for a Generalized ESD Many-Outlier ProcedureTechnometrics, 1983
- Decreased Nocturnal Plasma Melatonin Peak in Patients with Estrogen Receptor Positive Breast CancerScience, 1982
- Urinary melatonin levels in human breast cancer patientsJournal of Neural Transmission, 1981